• Molecular Analysis of Triple Negative Breast cancer 

    Rance, Adam Henry
    Triple negative breast cancer (TNBC) is a heterogeneous and aggressive subtype making up 10-20% of newly diagnosed invasive breast cancers and currently has no targeted agents approved for systemic therapy. However up to ...